Forecasting Health Assessment
18 months following a $20B acquisition, numerous accounting and planning system integrations, higher than normal turnover and new ways of viewing financial data, the Corporate FP&A team wanted to step-back and ask how the forecast process was going. Specifically, what was working well, what were the main points to use as a basis for improvement and to ensure the forecasting process was aligned with the business objectives and decision making. To help this, they used an outside consultant for a quick 3-week project. This discussion will focus on the framework and process used to collect, analyze and prepare an action plan on the Genzyme global corporate planning processes.